Digital Therapeutics Market Size, Growth Statistics Report 2028

Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Other Applications] and Distribution Channel (Patients, Providers, Payers, and Employers)

Publication Month: Feb 2022 | Report Code: TIPHC00002236 | No. of Pages: 165 | Category: Healthcare IT | Status: Published

The digital therapeutics market is expected to grow from US$ 4,226.94 million in 2021 to US$ 18,061.79 million by 2028; it is estimated to grow at a CAGR of 23.1% from 2021 to 2028.

Digital therapeutics provide evidence-based therapeutic intrusions to patients that focus on treating diseases and are managing them using the high-quality software. Furthermore, it enables the application of digital health technologies to treat a psychological ailment. They are used independently or with devices and medications to optimize patient care and health outcomes.

The digital therapeutics market is segmented on the basis of application, distribution channel, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends, technological advancements, market dynamics, and the competitive analysis of the globally leading market players.

Strategic Insights

Lucrative Regions for Digital Therapeutics Market

Lucrative Regions for Digital Therapeutics Market

Get more information on this report :


Market Insights

Rising Prevalence of Chronic Diseases to Drive Digital Therapeutics Market Growth during Forecast Period

Chronic diseases, such as heart disease, stroke, diabetes, and obesity, account for the maximum healthcare costs in various country. According to a report by the World Health Organization (WHO), the number of diabetic adults is expected to rise from 463 million in 2020 to 629 million by 2045. As per the Centers for Disease Control and Prevention (CDC) data published in 2018, 1.4 million people are diagnosed with diabetes every year in the US. Similarly, Asia Pacific, Europe, and the Middle East & Africa report a high prevalence of diabetes. In addition, the obesity rates are increasing rapidly in developed and developing economies due to inactive and unhealthy lifestyles. The data published by the Organization for Economic Co-operation (OECD) in 2017 stated that ~19.5% of the adult population was obese in the OECD area. This rate is less than 6% in Korea and Japan, and more than 30% in Hungary, New Zealand, Mexico, and the US. Therefore, the rising prevalence of chronic diseases propels the growth of the digital therapeutics market.

Application Insights

Based on application, the global digital therapeutics market is segmented into diabetes, cardiovascular diseases, central nervous system (CNS) diseases, respiratory diseases, smoking cessation, musculoskeletal diseases, and other applications. In 2021, the diabetes segment held the largest share of the market. Moreover, the same segment is expected to register the highest CAGR in the market during the forecast period. The increasing incidence of diabetes across the globe drives the market growth for this segment. According to the CDC, in 2020, ~34.2 million people have diabetes; and 10.5% of this population was in the US.

Distribution Channel Insights

Based on distribution channel, the global digital therapeutics market is segmented into patients, providers, payers, and employers. In 2021, the patients segment held the largest market share. However, the providers segment is expected to register the highest CAGR in the market during the forecast period. The market growth for the patients segment is attributed to the increased adoption of digital therapeutic solutions by patients, as they are primary users of therapeutic healthcare applications and programs. The demand for digital therapeutics is rising due to the growing number of patients suffering from chronic conditions.

Digital Therapeutics Market, by Application – during 2021–2028

Digital Therapeutics Market, by Application – during 2021–2028

Get more information on this report :


Product launches and collaborations are highly adopted strategies by the global digital therapeutics market players. A few of the recent key market developments are listed below:

  • In May 2021, Teladoc Health, Inc. launched myStrength Complete, an integrated mental health service provides personalized and targeted care to consumers in a single and comprehensive experience.
  • In April 2020, Omada Health launched the Omada Insights Lab, its internal initiative that leverages Omada’s deep multidisciplinary expertise to transform care delivery and apply learnings into innovative and cost-effective interventions.
  • In February 2021, Fitbit and Diabetes UK, the leading charity for people affected by diabetes, announced a new three-year partnership. They will work together to educate people on the importance of understanding their health and how leading a healthier and more active lifestyle can play a critical role in preventing type 2 diabetes and managing all types of diabetes.

The overall impact of the COVID-19 pandemic on the digital therapeutics market is rising, as demand for convenient and accessible digital health solutions surged during the crisis. The April 2020 guidelines released by the Food and Drug Administration (FDA) stated that it would allow the distribution and use of digital health therapeutic devices for mental health disorders for the duration of the pandemic. The Software Pre-Cert Pilot Program, part of the FDA's Digital Health Innovation Action Plan, is intended for efficient regulatory oversight of Software-based Medical Devices (SaMD) developed by manufacturers.

In other regions as well people started using digital therapeutics to manage their health at home as due to pandemic non-essential hospital visits were restricted.

Thus, the COVID-19 outbreak positively impacted the digital therapeutics market.

Digital Therapeutics – Market Segmentation

The global digital therapeutics market is segmented on the basis of application, distribution channel, and geography. Based on application, the market is categorized into diabetes, cardiovascular diseases, central nervous system (CNS) diseases, respiratory diseases, smoking cessation, musculoskeletal diseases, and other applications. Based on distribution channel, the digital therapeutics market is segmented into patients, providers, payers, and employers. By geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America.

Company Profiles

  • Propeller Health
  • Canary Health, Inc.
  • NOOM, INC.
  • 2Morrow, Inc.
  • Teladoc Health
  • Welldoc, Inc.
  • FITBIT, Inc.
  • OMADA Health
  • Mango Health
  • Pear Therapeutics, Inc.
  • Happify Health

Frequently Asked Questions

The digital therapeutics market majorly consists of the players such as Propeller Health; Canary Health, Inc.; NOOM, INC.; 2Morrow, Inc.; Teladoc Health; Welldoc, Inc.; FITBIT, Inc.; OMADA Health; Mango Health; Pear Therapeutics, Inc.; and Happify Health.
Factors such as the rising prevalence of chronic diseases and the growing need to reduce healthcare costs are driving the digital therapeutics market. However, cyber threats and risks related to data security are hampering the market growth.
Digital therapeutics provide evidence-based therapeutic intrusions to patients that focus on the treatment of diseases with the programs by using the high-quality software. Digital therapeutics have made progress in the last few years, harnessing technology for the supplement or potentially replacing traditional clinical therapy. They are used independently or with devices and medications for the optimization of patient care and health outcomes.
The global digital therapeutics market, based on application, is segmented into diabetes, cardiovascular diseases, central nervous system (CNS) disease, respiratory diseases, smoking cessation, musculoskeletal diseases, and others. The diabetes segment held the largest share of the market in 2021 and the same segment registered the highest CAGR during the forecast period.

1. Introduction 23

1.1 Scope of the Study. 23

1.2 The Insight Partners Research Report Guidance. 23

1.3 Market Segmentation. 24

1.3.1 Digital Therapeutics Market– By Application. 25

1.3.2 Digital Therapeutics Market– By Distribution Channel 25

1.3.3 Digital Therapeutics Market– By Geography. 26

2. Digital Therapeutics Market– Key Takeaways 28

3. Research Methodology 34

3.1 Coverage. 35

3.2 Secondary Research. 35

3.3 Primary Research. 35

4. Global Digital Therapeutics Market– Market Landscape 37

4.1 Overview. 37

4.2 PEST Analysis. 37

4.2.1 North America: PEST Analysis. 37

4.2.2 Europe: PEST Analysis. 38

4.2.3 Asia Pacific: PEST Analysis. 38

4.2.4 Middle East and Africa: PEST Analysis. 39

4.2.5 South and Central America: PEST Analysis. 39

4.3 Expert Opinion. 40

5. Digital Therapeutics Market– Key Market Dynamics 41

5.1 Market Drivers. 41

5.1.1 Rising Prevalence of Chronic Diseases. 41

5.1.2 Concerns Regarding Need to Reduce Healthcare Costs. 42

5.1.3 Partnerships and Collaborations by Companies. 42

5.2 Market Restraints. 43

5.2.1 Cyber Threat and Rise in Data Security. 43

5.3 Market Opportunities. 43

5.3.1 Large Population with Undiagnosed Conditions. 43

5.4 Future Trends. 44

5.4.1 Increasing Number of Start-Ups. 44

5.5 Impact analysis. 45

6. Digital Therapeutics Market– Global Analysis 46

6.1 Global Digital Therapeutics Market Revenue Forecast and Analysis. 46

6.2 Global Digital Therapeutics Market, By Geography - Forecast and Analysis. 47

6.3 Market Positioning of Key Players. 48

7. Digital Therapeutics Market Analysis – By Application 49

7.1 Overview. 49

7.2 Digital Therapeutics Market Revenue Share, by Application (2021 and 2028) 49

7.3 Diabetes. 50

7.3.1 Overview.. 50

7.3.2 Diabetes: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 50

7.3.3 Cardiovascular Disease. 51

7.3.3.1 Overview.. 51

7.3.3.2 Cardiovascular Disease: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 51

7.3.4 Central Nervous System Diseases. 52

7.3.4.1 Overview.. 52

7.3.4.2 Central Nervous System Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 52

7.3.5 Respiratory Diseases. 53

7.3.5.1 Overview.. 53

7.3.5.2 Respiratory Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 53

7.3.6 Smoking Cessation. 54

7.3.6.1 Overview.. 54

7.3.6.2 Smoking Cessation: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 54

7.3.7 Musculoskeletal Disorders. 55

7.3.7.1 Overview.. 55

7.3.7.2 Musculoskeletal Disorders: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 55

7.3.8 Others. 55

7.3.8.1 Overview.. 55

7.3.8.2 Others: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 56

8. Digital Therapeutics Market Analysis – By Distribution Channel 57

8.1 Overview. 57

8.2 Digital Therapeutics Market Revenue Share, by Distribution Channel (2021 and 2028) 57

8.3 Patients. 57

8.3.1 Overview.. 57

8.3.2 Patients: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million) 58

8.4 Providers. 59

8.4.1 Overview.. 59

8.4.2 Providers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million) 59

8.5 Payers. 60

8.5.1 Overview.. 60

8.5.2 Payers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million) 60

8.6 Employers. 61

8.6.1 Overview.. 61

8.6.2 Employers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million) 61

9. Digital Therapeutics Market– Geographical Analysis 62

9.1 North America: Digital Therapeutics Market 62

9.1.1 Overview.. 62

9.1.2 North America: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 63

9.1.3 North America: Digital Therapeutics Market, by Application, 2019–2028 (US$ Million) 63

9.1.4 North America: Digital Therapeutics Market, by Distribution Channel, 2019–2028 (US$ Million) 64

9.1.5 North America: Digital Therapeutics Market, by Country, 2021 & 2028 (%) 64

9.1.5.1 US: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 64

9.1.5.1.1 Overview.. 64

9.1.5.1.2 US: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 65

9.1.5.1.3 US: Digital Therapeutics Market, by Application, 2019–2028 (US$ Million) 66

9.1.5.1.4 US: Digital Therapeutics Market, by Distribution Channel, 2019–2028 (US$ Million) 66

9.1.5.2 Canada: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 67

9.1.5.2.1 Overview.. 67

9.1.5.2.2 Canada: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 67

9.1.5.2.3 Canada: Digital Therapeutics Market, by Application, 2019–2028 (US$ Million) 68

9.1.5.2.4 Canada: Digital Therapeutics Market, by Distribution Channel, 2019–2028 (US$ Million) 69

9.1.5.3 Mexico: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 69

9.1.5.3.1 Overview.. 69

9.1.5.3.2 Mexico: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 70

9.1.5.3.3 Mexico: Digital Therapeutics Market, by Application, 2019–2028 (US$ Million) 70

9.1.5.3.4 Mexico: Digital Therapeutics Market, by Distribution Channel, 2019–2028 (US$ Million) 71

9.2 Europe: Digital Therapeutics Market 72

9.2.1 Overview.. 72

9.2.2 Europe: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 73

9.2.3 Europe: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million) 73

9.2.4 Europe: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million) 74

9.2.5 Europe: Digital Therapeutics Market, by Country, 2021 & 2028 (%) 74

9.2.5.1 Germany: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 74

9.2.5.1.1 Overview.. 74

9.2.5.1.2 Germany: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 75

9.2.5.1.3 Germany: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million) 76

9.2.5.1.4 Germany: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million) 76

9.2.5.2 France: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 77

9.2.5.2.1 Overview.. 77

9.2.5.2.2 France: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 77

9.2.5.2.3 France: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million) 78

9.2.5.2.4 France: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million) 78

9.2.5.3 UK: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 79

9.2.5.3.1 Overview.. 79

9.2.5.3.2 UK: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 79

9.2.5.3.3 UK: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million) 80

9.2.5.3.4 UK: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million) 81

9.2.5.4 Italy: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 81

9.2.5.4.1 Overview.. 81

9.2.5.4.2 Italy: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 82

9.2.5.4.3 Italy: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million) 82

9.2.5.4.4 Italy: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million) 83

9.2.5.5 Spain: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 83

9.2.5.5.1 Overview.. 83

9.2.5.5.2 Spain: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 84

9.2.5.5.3 Spain: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million) 84

9.2.5.5.4 Spain: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million) 85

9.2.5.6 Rest of Europe: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 85

9.2.5.6.1 Overview.. 85

9.2.5.6.2 Rest of Europe: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 86

9.2.5.6.3 Rest of Europe: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million) 86

9.2.5.6.4 Rest of Europe: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million) 87

9.3 Asia Pacific Digital Therapeutics Market Revenue and Forecasts To 2028. 88

9.3.1 Overview.. 88

9.3.2 Asia Pacific Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 89

9.3.3 Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 89

9.3.4 Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million) 90

9.3.5 Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Country (%) 90

9.3.5.1 Japan: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 90

9.3.5.1.1 Overview.. 90

9.3.5.1.2 Japan: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 91

9.3.5.1.3 Japan: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 92

9.3.5.1.4 Japan: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million) 92

9.3.5.2 China: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 93

9.3.5.2.1 Overview.. 93

9.3.5.2.2 China: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 94

9.3.5.2.3 China: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 94

9.3.5.2.4 China: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million) 95

9.3.5.3 India Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 95

9.3.5.3.1 Overview.. 95

9.3.5.3.2 India: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 96

9.3.5.3.3 India: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 97

9.3.5.3.4 India: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million) 97

9.3.5.4 South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 98

9.3.5.4.1 Overview.. 98

9.3.5.4.2 South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 98

9.3.5.4.3 South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 99

9.3.5.4.4 South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million) 99

9.3.5.5 Australia: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 100

9.3.5.5.1 Overview.. 100

9.3.5.5.2 Australia: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 100

9.3.5.5.3 Australia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 101

9.3.5.5.4 Australia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million) 101

9.3.5.6 Rest of Asia Pacific: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 102

9.3.5.6.1 Overview.. 102

9.3.5.6.2 Rest of Asia Pacific: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million) 102

9.3.5.6.3 Rest of Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 103

9.3.5.6.4 Rest of Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million) 103

9.4 Middle East & Africa Digital Therapeutics Market Revenue and Forecasts To 2028. 104

9.4.1 Overview.. 104

9.4.2 Middle East & Africa Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 105

9.4.3 Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 105

9.4.4 Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million) 106

9.4.5 Middle East & Africa Digital Therapeutics Market Revenue and Forecasts to 2028, By Country (%) 106

9.4.5.1 UAE: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 106

9.4.5.1.1 Overview.. 106

9.4.5.1.2 UAE: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 107

9.4.5.1.3 UAE: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 107

9.4.5.1.4 UAE: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million) 108

9.4.5.2 Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 108

9.4.5.2.1 Overview.. 108

9.4.5.2.2 Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 109

9.4.5.2.3 Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 109

9.4.5.2.4 Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million) 110

9.4.5.3 South Africa: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 110

9.4.5.3.1 Overview.. 110

9.4.5.3.2 South Africa Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 111

9.4.5.3.3 South Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 111

9.4.5.3.4 South Africa: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million) 112

9.4.5.4 Rest of Middle East and Africa: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 112

9.4.5.4.1 Overview.. 112

9.4.5.4.2 Rest of Middle East and Africa: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 113

9.4.5.4.3 Rest of Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 113

9.4.5.4.4 Rest of Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million) 114

9.5 South And Central America Digital Therapeutics Market Revenue and Forecasts To 2028. 115

9.5.1 Overview.. 115

9.5.2 South and Central America Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 116

9.5.3 South and Central America Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 116

9.5.4 South and Central America: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million) 117

9.5.5 South and Central America Digital Therapeutics Market Revenue and Forecasts to 2028, By Country (%) 117

9.5.5.1 Argentina Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 118

9.5.5.1.1 Overview.. 118

9.5.5.1.2 Argentina Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 118

9.5.5.1.3 Argentina: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 119

9.5.5.1.4 Argentina: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million) 119

9.5.5.2 Brazil: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 120

9.5.5.2.1 Overview.. 120

9.5.5.2.2 Brazil: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million) 121

9.5.5.2.3 Brazil: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 121

9.5.5.2.4 Brazil: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million) 122

9.5.5.3 Rest of South and Central America: Digital Therapeutics Market– Revenue and Forecast to 2028 (USD Mn) 122

9.5.5.3.1 Overview.. 122

9.5.5.3.2 Rest of South and Central America: Digital Therapeutics Market– Revenue and Forecast to 2028 (USD Mn) 123

9.5.5.3.3 Rest of South & Central America: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million) 123

9.5.5.3.4 Rest of South & Central America: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million) 124

10. Impact of COVID-19 Pandemic on Global Digital Therapeutics Market 125

10.1 North America: Impact Assessment of COVID-19 Pandemic. 125

10.2 Europe: Impact Assessment of COVID-19 Pandemic. 126

10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic. 127

10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic. 128

10.5 South and Central America: Impact Assessment of COVID-19 Pandemic. 129

11. Digital Therapeutics Market –Industry Landscape 130

11.1 Overview. 130

11.2 Growth Strategies in the Digital Therapeutics Market, 2021-2028. 130

11.3 Inorganic Growth Strategies. 131

11.3.1 Overview.. 131

11.4 Organic Growth Strategies. 133

11.4.1 Overview.. 133

12. Company Profiles 136

12.1 Propeller Health (ResMed) 136

12.1.1 Key Facts. 136

12.1.2 Business Description. 136

12.1.3 Products and Services. 136

12.1.4 Financial Overview.. 137

12.1.5 SWOT Analysis. 137

12.1.6 Key Developments. 137

12.2 Canary Health. 138

12.2.1 Key Facts. 138

12.2.2 Business Description. 138

12.2.3 Products and Services. 138

12.2.4 Financial Overview.. 138

12.2.5 SWOT Analysis. 139

12.2.6 Key Developments. 139

12.3 Noom, Inc. 140

12.3.1 Key Facts. 140

12.3.2 Business Description. 140

12.3.3 Products and Services. 140

12.3.4 Financial Overview.. 140

12.3.5 SWOT Analysis. 141

12.3.6 Key Developments. 141

12.4 2Morrow, Inc. 142

12.4.1 Key Facts. 142

12.4.2 Business Description. 142

12.4.3 Products and Services. 142

12.4.4 Financial Overview.. 142

12.4.5 SWOT Analysis. 143

12.4.6 Key Developments. 143

12.5 Teladoc Health, Inc. 144

12.5.1 Key Facts. 144

12.5.2 Business Description. 144

12.5.3 Products and Services. 144

12.5.4 Financial Overview.. 145

12.5.5 SWOT Analysis. 146

12.5.6 Key Developments. 146

12.6 Welldoc, Inc. 147

12.6.1 Key Facts. 147

12.6.2 Business Description. 147

12.6.3 Products and Services. 147

12.6.4 Financial Overview.. 148

12.6.5 SWOT Analysis. 148

12.6.6 Key Developments. 148

12.7 Fitbit, Inc. 150

12.7.1 Key Facts. 150

12.7.2 Business Description. 150

12.7.3 Products and Services. 150

12.7.4 Financial Overview.. 151

12.7.5 SWOT Analysis. 152

12.7.6 Key Developments. 153

12.8 Omada Health, Inc. 154

12.8.1 Key Facts. 154

12.8.2 Business Description. 154

12.8.3 Products and Services. 154

12.8.4 Financial Overview.. 154

12.8.5 SWOT Analysis. 155

12.8.6 Key Developments. 155

12.9 MANGO HEALTH. 156

12.9.1 Key Facts. 156

12.9.2 Business Description. 156

12.9.3 Products and Services. 156

12.9.4 Financial Overview.. 156

12.9.5 SWOT Analysis. 157

12.9.6 Key Developments. 157

12.10 Pear Therapeutics, Inc. 158

12.10.1 Key Facts. 158

12.10.2 Business Description. 158

12.10.3 Products and Services. 158

12.10.4 Financial Overview.. 158

12.10.5 SWOT Analysis. 159

12.10.6 Key Developments. 159

12.11 Happify Health. 161

12.11.1 Key Facts. 161

12.11.2 Business Description. 161

12.11.3 Products and Services. 161

12.11.4 Financial Overview.. 161

12.11.5 SWOT Analysis. 162

12.11.6 Key Developments. 162

13. Appendix 163

13.1 About the Insight Partners. 163

13.2 Glossary of Terms. 163

LIST OF TABLES

Table 1. Proportion Of People Living With Undiagnosed Diabetes (20–79 years) Per Region, 2021

Table 2. North America Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)

Table 4. US Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 5. US Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 6. Canada: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 7. Canada Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 8. Mexico: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 9. Mexico Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 10. Europe: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11. Europe: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 12. Germany: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 13. Germany: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 14. France: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 15. France: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million).

Table 16. UK: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 17. UK: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 18. Italy: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 19. Italy: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 20. Spain: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 21. Spain: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 22. Rest of Europe: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 23. Rest of Europe: Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 24. Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million).

Table 25. Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 26. Japan: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 27. Japan: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 28. China: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 29. China: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 30. India: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 31. India: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 32. South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 33. South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 34. Australia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 35. Australia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 36. Rest of Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 37. Rest of Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 38. Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 39. Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 40. UAE: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 41. UAE: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 42. Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 43. Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 44. South Africa Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 45. South Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 46. Rest of Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 47. Rest of Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 48. South and Central America Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 49. South and Central America: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 50. Argentina: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 51. Argentina: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 52. Brazil: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 53. Brazil: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 54. Rest of South & Central America: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 55. Rest of South & Central America: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)

Table 56. Growth Strategies in the Digital Therapeutics Market, 2021-2028

Table 57. Recent Inorganic Growth Strategies in the Digital Therapeutics Market

Table 58. Recent Organic Growth Strategies in the Digital Therapeutics Market

Table 59. Glossary of Terms, Digital Therapeutics Market

LIST OF FIGURES

Figure 1. Digital Therapeutics Market Segmentation

Figure 2. Digital Therapeutics Market– By Geography

Figure 3. Digital Therapeutics Market Overview

Figure 4. Diabetes Segment Held Largest Share of Digital Therapeutics Market by Application

Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

Figure 6. Digital Therapeutics Market, by Geography (US$ Million)

Figure 7. Global Digital Therapeutics Market– Leading Country Markets (US$ Million)

Figure 8. Global Digital Therapeutics Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East and Africa: PEST Analysis

Figure 13. South and Central America: PEST Analysis

Figure 14. Expert Opinion

Figure 15. Digital Therapeutics market impact analysis of driver and restraints

Figure 16. Global Digital Therapeutics Market – Revenue Forecast and Analysis – 2021 - 2028

Figure 17. Global Digital Therapeutics Market– By Geography Forecast and Analysis – 2021- 2028

Figure 18. Market Positioning of Key Players in Global Digital Therapeutics Market

Figure 19. Digital Therapeutics Market Revenue Share, by Application (2021 and 2028)

Figure 20. Diabetes: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Cardiovascular Disease: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Central Nervous System Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Respiratory Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Smoking Cessation: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Musculoskeletal Disorders: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Others: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Digital Therapeutics Market Revenue Share, by Distribution Channel (2021 and 2028)

Figure 28. Patients: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 29. Providers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30. Payers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. Employers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32. North America: Digital Therapeutics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 33. North America Digital Therapeutics Market Revenue and Forecast to 2028 (US$ Million)

Figure 34. North America: Digital Therapeutics Market, by Country, 2021 & 2028 (%)

Figure 35. US: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Canada: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Mexico: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Europe: Digital Therapeutics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 39. Europe: Digital Therapeutics Market Revenue and Forecast to 2028 (US$ Million)

Figure 40. Europe: Digital Therapeutics Market, by Country, 2021 & 2028 (%)

Figure 41. Germany: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. France: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. UK: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44. Italy: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45. Spain: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46. Rest of Europe: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47. Asia Pacific Digital Therapeutics Market Overview, by Country (2021)

Figure 48. Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 49. Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Country (%)

Figure 50. Japan: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 51. China: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 52. India: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 53. South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 54. Australia: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 55. Rest of Asia Pacific: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 56. Middle East & Africa Digital Therapeutics Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 57. Middle East & Africa Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 58. Middle East & Africa Digital Therapeutics Market Revenue and Forecasts to 2028, By Country (%)

Figure 59. UAE: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 60. Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 61. South Africa: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 62. Rest of Middle East and Africa: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 63. South and Central America Digital Therapeutics Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 64. South and Central America Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 65. South and Central America Digital Therapeutics Market Revenue and Forecasts to 2028, By Country (%)

Figure 66. Argentina Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 67. Brazil: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 68. Rest of South and Central America: Digital Therapeutics Market– Revenue and Forecast to 2028 (USD Mn)

Figure 69. Impact of COVID-19 Pandemic in North American Country Markets

Figure 70. Impact of COVID-19 Pandemic in European Country Markets

Figure 71. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 72. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 73. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

The List of Companies - Digital Therapeutics Market

  1. Propeller Health
  2. Canary Health
  3. NOOM, INC.
  4. 2MORROW, INC.
  5. Teladoc Health
  6. Welldoc, Inc.
  7. FITBIT, INC.
  8. OMADA Health
  9. Mango Health
  10. Pear Therapeutics, Inc.
  11. HAPPIFY Health.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the digital therapeutics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global digital therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TIPHC00002236
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount